Duroply Indust.

- The company expects growth to continue into the coming year, supported by initiatives started last year beginning to bear fruit (Page 17). - A strong sales team and expanded channel and influencer networks are contributing to recent growth, with expectations to sustain better-than-15% growth in coming quarters (Pages 6, 7). - The mid-segment brand "Tower" is the fastest-growing segment, contributing 25% of revenue and growing faster than the premium "Duro" range (Page 9). - Expansion focus is on regions beyond North India, with a 2-3 year horizon to build significant presence in South and West India (Page 6). - The company targets high teens growth rates over the next couple of years, reflecting confidence in scaling operations and market expansion (Page 11).

- The company expects continued growth in the coming year, building on initiatives started last year that are beginning to bear fruit. - They target a high teens growth rate over the next 2 years. - Operating margins are projected to improve gradually, aiming for the high single digits (8%-9.5%) within 2 years. - EBITDA margins improved to 5.4% in Q4 FY25 with expectations of further margin expansion through scale and cost efficiencies. - Profit before tax for FY25 was Rs. 5.81 crores up from Rs. 1.01 crores in FY24, showing positive profit momentum. - Increased focus on sales team expansion, channel network, and product mix enhancement are key drivers for revenue and margin growth. - Raw material costs are expected to soften in the latter half of the year, aiding margin improvement.

The transcript provided from the PDF "2897.pdf" does not mention any details regarding the current or expected order book or pending orders of Duroply. The discussion focuses mainly on: - Revenue mix (95% B2B, 5% retail) - Growth drivers and brand expansion - Impact of BIS norms on imports and the market - Financial metrics like margins, costs, working capital - Equity infusion and financial health - Market share and competitive dynamics No specific information on order book or pending orders is disclosed in the provided pages, including page 17. If you need details on the order book, it might be covered elsewhere in the report or earnings call transcript not included here.

- No major fundraising plans through debt or equity were mentioned for the near future. - Recent fund infusions include ₹28 crores equity in September 2022 and ₹44.9 crores equity announced in March 2024, with some warrants pending conversion. - The company is currently focusing on strengthening its balance sheet and expanding operations using these existing funds. - CapEx is limited to maintenance and efficiency improvements at the Rajkot plant, with no major expansions planned. - The financial position is strong following recent equity infusions, and the company is confident in its growth trajectory without needing immediate additional fundraising.

- Current CapEx is focused on improving efficiencies at their plant in Rajkot. - This primarily involves maintenance, debottlenecking, and efficiency enhancements. - There are no major new CapEx plans on the near horizon. - The company has made strategic equity infusions recently (₹28 crores in Sept 2022 and ₹44.9 crores in March 2024) to strengthen the balance sheet and support growth initiatives. - Investments have been made in infrastructure, sales team expansion, and supply chain improvements. - The focus is on growing existing product lines rather than major new product expansions.